ApprovalTrail

Approval · Notice of Compliance 12056 · 2011

RALIVIA: Notice of Compliance 12056

Issued February 10, 2011

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
12056
Date
February 10, 2011
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Opioid analgesic

Products in this notice

BrandDINStatus today
RALIVIA02299194Marketed
RALIVIA02299208Marketed
RALIVIA02299216Marketed

Medicinal ingredients